Global Healthcare Regulatory Affairs Outsourcing Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Healthcare Regulatory Affairs Outsourcing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Healthcare Regulatory Affairs Outsourcing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Regulatory Writing and Publishing
  • 1.4.3 Regulatory Submissions
  • 1.4.4 Clinical Trial Applications
  • 1.4.5 Product Registrations
  • 1.4.6 Regulatory Consulting and Legal Representation
  • 1.4.7 Others
• 1.5 Market by Application
  • 1.5.1 Global Healthcare Regulatory Affairs Outsourcing Market Share by Application: 2020 VS 2026
  • 1.5.2 Mid-Size Pharmaceutical Companies
  • 1.5.3 Large Pharmaceutical Companies
  • 1.5.4 Biotechnology Companies
  • 1.5.5 Medical Devices Manufacturer
  • 1.5.6 Food & Beverage Companies
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Healthcare Regulatory Affairs Outsourcing Market Perspective (2015-2026)
• 2.2 Global Healthcare Regulatory Affairs Outsourcing Growth Trends by Regions
  • 2.2.1 Healthcare Regulatory Affairs Outsourcing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Healthcare Regulatory Affairs Outsourcing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Healthcare Regulatory Affairs Outsourcing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Healthcare Regulatory Affairs Outsourcing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Healthcare Regulatory Affairs Outsourcing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Healthcare Regulatory Affairs Outsourcing Players by Market Size
  • 3.1.1 Global Top Healthcare Regulatory Affairs Outsourcing Players by Revenue (2015-2020)
  • 3.1.2 Global Healthcare Regulatory Affairs Outsourcing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Healthcare Regulatory Affairs Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Healthcare Regulatory Affairs Outsourcing Market Concentration Ratio
  • 3.2.1 Global Healthcare Regulatory Affairs Outsourcing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Healthcare Regulatory Affairs Outsourcing Revenue in 2019
• 3.3 Healthcare Regulatory Affairs Outsourcing Key Players Head office and Area Served
• 3.4 Key Players Healthcare Regulatory Affairs Outsourcing Product Solution and Service
• 3.5 Date of Enter into Healthcare Regulatory Affairs Outsourcing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Healthcare Regulatory Affairs Outsourcing Historic Market Size by Type (2015-2020)
• 4.2 Global Healthcare Regulatory Affairs Outsourcing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Healthcare Regulatory Affairs Outsourcing Market Size by Application (2015-2020)
• 5.2 Global Healthcare Regulatory Affairs Outsourcing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Healthcare Regulatory Affairs Outsourcing Market Size (2015-2020)
• 6.2 Healthcare Regulatory Affairs Outsourcing Key Players in North America (2019-2020)
• 6.3 North America Healthcare Regulatory Affairs Outsourcing Market Size by Type (2015-2020)
• 6.4 North America Healthcare Regulatory Affairs Outsourcing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Healthcare Regulatory Affairs Outsourcing Market Size (2015-2020)
• 7.2 Healthcare Regulatory Affairs Outsourcing Key Players in Europe (2019-2020)
• 7.3 Europe Healthcare Regulatory Affairs Outsourcing Market Size by Type (2015-2020)
• 7.4 Europe Healthcare Regulatory Affairs Outsourcing Market Size by Application (2015-2020)

8 China

• 8.1 China Healthcare Regulatory Affairs Outsourcing Market Size (2015-2020)
• 8.2 Healthcare Regulatory Affairs Outsourcing Key Players in China (2019-2020)
• 8.3 China Healthcare Regulatory Affairs Outsourcing Market Size by Type (2015-2020)
• 8.4 China Healthcare Regulatory Affairs Outsourcing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Healthcare Regulatory Affairs Outsourcing Market Size (2015-2020)
• 9.2 Healthcare Regulatory Affairs Outsourcing Key Players in Japan (2019-2020)
• 9.3 Japan Healthcare Regulatory Affairs Outsourcing Market Size by Type (2015-2020)
• 9.4 Japan Healthcare Regulatory Affairs Outsourcing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Healthcare Regulatory Affairs Outsourcing Market Size (2015-2020)
• 10.2 Healthcare Regulatory Affairs Outsourcing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Healthcare Regulatory Affairs Outsourcing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Healthcare Regulatory Affairs Outsourcing Market Size by Application (2015-2020)

11 India

• 11.1 India Healthcare Regulatory Affairs Outsourcing Market Size (2015-2020)
• 11.2 Healthcare Regulatory Affairs Outsourcing Key Players in India (2019-2020)
• 11.3 India Healthcare Regulatory Affairs Outsourcing Market Size by Type (2015-2020)
• 11.4 India Healthcare Regulatory Affairs Outsourcing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Healthcare Regulatory Affairs Outsourcing Market Size (2015-2020)
• 12.2 Healthcare Regulatory Affairs Outsourcing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Healthcare Regulatory Affairs Outsourcing Market Size by Type (2015-2020)
• 12.4 Central & South America Healthcare Regulatory Affairs Outsourcing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 PAREXEL
  • 13.1.1 PAREXEL Company Details
  • 13.1.2 PAREXEL Business Overview
  • 13.1.3 PAREXEL Healthcare Regulatory Affairs Outsourcing Introduction
  • 13.1.4 PAREXEL Revenue in Healthcare Regulatory Affairs Outsourcing Business (2015-2020))
  • 13.1.5 PAREXEL Recent Development
• 13.2 Quintiles IMS
  • 13.2.1 Quintiles IMS Company Details
  • 13.2.2 Quintiles IMS Business Overview
  • 13.2.3 Quintiles IMS Healthcare Regulatory Affairs Outsourcing Introduction
  • 13.2.4 Quintiles IMS Revenue in Healthcare Regulatory Affairs Outsourcing Business (2015-2020)
  • 13.2.5 Quintiles IMS Recent Development
• 13.3 Clinilabs
  • 13.3.1 Clinilabs Company Details
  • 13.3.2 Clinilabs Business Overview
  • 13.3.3 Clinilabs Healthcare Regulatory Affairs Outsourcing Introduction
  • 13.3.4 Clinilabs Revenue in Healthcare Regulatory Affairs Outsourcing Business (2015-2020)
  • 13.3.5 Clinilabs Recent Development
• 13.4 Accell
  • 13.4.1 Accell Company Details
  • 13.4.2 Accell Business Overview
  • 13.4.3 Accell Healthcare Regulatory Affairs Outsourcing Introduction
  • 13.4.4 Accell Revenue in Healthcare Regulatory Affairs Outsourcing Business (2015-2020)
  • 13.4.5 Accell Recent Development
• 13.5 Freyr Solutions
  • 13.5.1 Freyr Solutions Company Details
  • 13.5.2 Freyr Solutions Business Overview
  • 13.5.3 Freyr Solutions Healthcare Regulatory Affairs Outsourcing Introduction
  • 13.5.4 Freyr Solutions Revenue in Healthcare Regulatory Affairs Outsourcing Business (2015-2020)
  • 13.5.5 Freyr Solutions Recent Development
• 13.6 Weinberg
  • 13.6.1 Weinberg Company Details
  • 13.6.2 Weinberg Business Overview
  • 13.6.3 Weinberg Healthcare Regulatory Affairs Outsourcing Introduction
  • 13.6.4 Weinberg Revenue in Healthcare Regulatory Affairs Outsourcing Business (2015-2020)
  • 13.6.5 Weinberg Recent Development
• 13.7 Covance
  • 13.7.1 Covance Company Details
  • 13.7.2 Covance Business Overview
  • 13.7.3 Covance Healthcare Regulatory Affairs Outsourcing Introduction
  • 13.7.4 Covance Revenue in Healthcare Regulatory Affairs Outsourcing Business (2015-2020)
  • 13.7.5 Covance Recent Development
• 13.8 Pharmaceutical Product Development
  • 13.8.1 Pharmaceutical Product Development Company Details
  • 13.8.2 Pharmaceutical Product Development Business Overview
  • 13.8.3 Pharmaceutical Product Development Healthcare Regulatory Affairs Outsourcing Introduction
  • 13.8.4 Pharmaceutical Product Development Revenue in Healthcare Regulatory Affairs Outsourcing Business (2015-2020)
  • 13.8.5 Pharmaceutical Product Development Recent Development
• 13.9 ICON
  • 13.9.1 ICON Company Details
  • 13.9.2 ICON Business Overview
  • 13.9.3 ICON Healthcare Regulatory Affairs Outsourcing Introduction
  • 13.9.4 ICON Revenue in Healthcare Regulatory Affairs Outsourcing Business (2015-2020)
  • 13.9.5 ICON Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer